1. Home
  2. PSBD vs PEPG Comparison

PSBD vs PEPG Comparison

Compare PSBD & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PSBD

Palmer Square Capital BDC Inc.

HOLD

Current Price

$12.26

Market Cap

385.0M

Sector

N/A

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.36

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSBD
PEPG
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
385.0M
317.6M
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
PSBD
PEPG
Price
$12.26
$5.36
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$13.30
$9.50
AVG Volume (30 Days)
78.1K
824.2K
Earning Date
11-05-2025
11-12-2025
Dividend Yield
13.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.51
$0.88
52 Week High
$16.16
$6.72

Technical Indicators

Market Signals
Indicator
PSBD
PEPG
Relative Strength Index (RSI) 51.63 51.50
Support Level $12.10 $5.04
Resistance Level $12.45 $6.72
Average True Range (ATR) 0.23 0.58
MACD 0.05 -0.06
Stochastic Oscillator 75.36 30.02

Price Performance

Historical Comparison
PSBD
PEPG

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: